A client prioritized a workstream aimed at ensuring FDA reviewers were well trained on cutting-edge science. Catalyst was tasked with advancing this client goal in a manner that created mutual benefits for both the client and the FDA.
Sign up for periodic updates on regulatory policy and events we are attending
